Since 2014, the widespread use of germline and somatic testing in gynecologic oncology has dramatically increased. The use of genetic testing can support actionable changes which may influence treatment decisions. Test results can inform risk for other malignancies and prompt preventive screenings for at-risk relatives. Despite an increasing awareness of the benefits of genetic testing, many patients are not receiving consistent or equitable testing.
CANCER BUZZ spoke to Melissa Frey, MD, MS, Assistant Professor, Division of Gynecologic Oncology, and Director, Genetics and Personalized Cancer Prevention Program, Weill Cornell Medicine in New York, New York, and Leigha Senter, MS, CGC, Professor, Clinical Internal Medicine, Associate Director, Division of Human Genetics, and Licensed Genetic Counselor, The Ohio State University in Columbus, Ohio. Listen as we discuss germline and somatic testing for patients with ovarian cancer.
“Ovarian cancer is probably one of the most exciting examples of the way genetics and genomics can inform treatment, and also improve patient care, and patient outcomes.”
Melissa Frey, MD, MS
“While we are putting a lot of effort into making sure patients get the testing they need, we also need to have a support web in place for their family members too. And that is actually a service to our patients.”
Leigha Senter, MS, CGC
Melissa Frey, MD, MS
Assistant Professor, Division of Gynecologic Oncology
Director, Genetics and Personalized Cancer Prevention Program
Weill Cornell Medicine
New York, New York
Leigha Senter, MS, CGC
Professor, Clinical Internal Medicine
Associate Director, Division of Human Genetics
Licensed Genetic Counselor
The Ohio State University
Columbus, Ohio
Resources:
Cancer Support Community
This project is supported by AstraZeneca and GlaxoSmithKline.
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
The Psychic Elephant Radio Podcast
DNA Today: A Genetics Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain